BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7873830)

  • 1. Spironolactone-associated cutaneous effects: a case report and a review of the literature.
    Gupta AK; Knowles SR; Shear NH
    Dermatology; 1994; 189(4):402-5. PubMed ID: 7873830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Generalized pruritic eruption during terbinafine treatment].
    Amouri M; El Euch D; El Ouni B; Daoued O; Ouselati MH; Ferjani M; Dhahri AB
    Presse Med; 2008 Dec; 37(12):1836-40. PubMed ID: 18656325
    [No Abstract]   [Full Text] [Related]  

  • 3. Gottron-like papules induced by hydroxyurea.
    Yoshida K; Saito M; Amagai M; Ikeda Y
    Clin Exp Dermatol; 2005 Mar; 30(2):191-2. PubMed ID: 15725256
    [No Abstract]   [Full Text] [Related]  

  • 4. Fixed drug eruption due to cimetidine.
    Inoue A; Teramae H; Hisa T; Taniguchi S; Chanoki M; Hamada T
    Acta Derm Venereol; 1995 May; 75(3):250. PubMed ID: 7653194
    [No Abstract]   [Full Text] [Related]  

  • 5. Lichenoid drug eruption induced by spironolactone.
    Schön MP; Tebbe B; Trautmann C; Orfanos CE
    Acta Derm Venereol; 1994 Nov; 74(6):476. PubMed ID: 7701889
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug-induced papular-purpuric gloves and socks syndrome].
    van Rooijen MM; Brand CU; Ballmer-Weber BK; Yawalkar N; Hunziker TK
    Hautarzt; 1999 Apr; 50(4):280-3. PubMed ID: 10354921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A maculopapular-type eruption associated with deferasirox administration.
    Ohshita A; Nakai N; Katoh N; Konishi K
    J Am Acad Dermatol; 2013 Nov; 69(5):e265-e267. PubMed ID: 24124858
    [No Abstract]   [Full Text] [Related]  

  • 8. Disseminated maculopapular eruption caused by leuprorelin acetate.
    Sugita K; Kabashima K; Tokura Y
    Eur J Dermatol; 2008; 18(5):603-4. PubMed ID: 18779115
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy.
    Lo JA; Fisher DE; Flaherty KT
    JAMA Oncol; 2015 Dec; 1(9):1340-1. PubMed ID: 26270186
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythema annulare centrifugum caused by aldactone].
    Carsuzaa F; Pierre C; Dubegny M
    Ann Dermatol Venereol; 1987; 114(3):375-6. PubMed ID: 2955736
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous reaction to spironolactone resembling lupus erythematosus.
    Uddin MS; Lynfield YL; Grosberg SJ; Stiefler R
    Cutis; 1979 Aug; 24(2):198-200. PubMed ID: 157853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous drug eruption induced by antihistamines.
    Viñas M; Castillo MJ; Hernández N; Ibero M
    Clin Exp Dermatol; 2014 Dec; 39(8):918-20. PubMed ID: 25394293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dermatitis caused by aldactone of a lupic annular erythema type].
    Leroy D; Dompmartin A; Le Jean S; Guillemain JL; Mandard JC; Deschamps P
    Ann Dermatol Venereol; 1987; 114(10):1237-40. PubMed ID: 2963578
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperkeratotic eruption, hand-foot skin reaction, facial erythema, and stomatitis secondary to multi-targeted kinase inhibitor sorafenib.
    Sahai S; Swick BL
    Int J Dermatol; 2010 Oct; 49(10):1203-6. PubMed ID: 20883411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Images in clinical medicine. Chemotherapy-induced acral erythema.
    Pirisi M; Soardo G
    N Engl J Med; 1994 May; 330(18):1279. PubMed ID: 8145783
    [No Abstract]   [Full Text] [Related]  

  • 16. Subungual fixed drug eruption.
    Benton EC; McGibbon D
    Br J Dermatol; 2010 Jun; 162(6):1397-8. PubMed ID: 20163418
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of skin testing in cutaneous drug eruptions in routine practice.
    Tchen T; Reguiaï Z; Vitry F; Arnoult E; Grange A; Florent G; Bernard P
    Contact Dermatitis; 2009 Sep; 61(3):138-44. PubMed ID: 19780771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and painful erythema of the hands and feet. Acral erythema induced by chemotherapy.
    Revenga Arranz F; Fernández-Durán DA; Grande C; Rodríguez Peralto JL; Vanaclocha Sebastián F
    Arch Dermatol; 1997 Apr; 133(4):499-500, 502-3. PubMed ID: 9126025
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous adverse events of epidermal growth factor receptor inhibitors: A retrospective review of 99 cases.
    Chanprapaph K; Pongcharoen P; Vachiramon V
    Indian J Dermatol Venereol Leprol; 2015; 81(5):547. PubMed ID: 25994883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous reaction to pancuronium.
    Noreng MF
    Br J Anaesth; 1985 Dec; 57(12):1269. PubMed ID: 2935179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.